All lobbying filings
American Society for Microbiology
American Society for Microbiology filed a Q1 report for American Society for Microbiology on April 20, 2026.
Lobbying for American Society for Microbiology
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Expenses
$50,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
District of Columbia
Government bodies contacted
2
Lobbying activity
4
Antimicrobial resistance; advanced molecular detection; national wastewater surveillance system (S.4048 - PREDICT Act), PAMA reform: RESULTS Act (H.R. 5269 S.2761)
Fiscal Year 2027 appropriations for NIH, CDC, NSF, DOE Office of Science, USDA research programs.
Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235); Cloud Labs to Advance Biotechnology Act of 2025 (S. 2676);
Microbiome research impact on agricultural sciences.